The US Food and Drug Administration (FDA) asked Israel’s Health Ministry to brief the agency’s advisory committee on booster-shot data at the panel’s September 17 meeting, according to Sharon Alroy-Preis, the ministry’s head of public health.
“We have been asked to come and present Israel’s experience and our data so that we can truly help the whole world to learn,” Alroy-Preis said on Sunday in an interview with the country’s Channel 12 TV.
Israel launched its booster-shot program on August 1, citing the waning efficacy of Covid-19 vaccines over time, and has so far administered the additional jabs to about 2.6 million people, or roughly 28% of the population.
Last week, Israel expanded the availability of third doses to all residents 12 and older, even as Covid-19 cases continued to surge amid the rollout. Health Ministry officials predict a drop in cases in the coming days, and hope the country will reach the so-called herd immunity “in the next month or two.”
Critics, however, fear the country is headed towards a “perpetual cycle of jabs,” as authorities said vaccinated people will lose their “green pass” privileges not only six months after the holder receives a second dose, but also six months after their third jab.
Two high-level FDA vaccine officials quit the agency last month, reportedly at least in part because President Joe Biden’s administration announced plans for booster shots to start being administered on September 20, despite not having secured approval from regulators. Other US health officials have urged the White House to hold off on the program until data has been adequately reviewed.